Aterian, Inc. (ATER)
| Market Cap | 23.28M |
| Revenue (ttm) | 127.90M |
| Net Income (ttm) | -53.93M |
| Shares Out | 8.44M |
| EPS (ttm) | -8.20 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 115,910 |
| Open | 2.450 |
| Previous Close | 2.540 |
| Day's Range | 2.450 - 2.830 |
| 52-Week Range | 0.231 - 3.950 |
| Beta | 1.99 |
| Analysts | Strong Buy |
| Price Target | n/a |
| Earnings Date | Aug 6, 2024 |
About ATER
Aterian, Inc., together with its subsidiaries, operates as a technology-enabled consumer products company in North America and internationally. Its platform offers home and kitchen appliances; kitchenware; cooling and air quality appliances, such as dehumidifiers; health and beauty products; and essential oils under the Squatty Potty, hOmeLabs, Mueller, Pursteam, Healing Solutions, and Photo Paper Direct brand names. The company primarily serves individual online consumers through online retail channels, such as Amazon and Walmart, as well as t... [Read more]
Financial Performance
In 2023, Aterian's revenue was $142.57 million, a decrease of -35.54% compared to the previous year's $221.17 million. Losses were -$74.56 million, -62.01% less than in 2022.
Financial StatementsNews
Aterian Announces Leadership Changes & Improved Second Quarter 2024 Net Revenue and Adjusted EBITDA Ranges
Arturo Rodriguez Appointed CEO Josh Feldman Appointed CFO Second Quarter 2024 Net Revenue Range Improved to Between $23 Million to $26 Million Second Quarter 2024 Adjusted EBITDA Range Improved to Bet...
Aterian Investment Partners Acquires Contract Pharmaceuticals Limited
NEW YORK & MIAMI--(BUSINESS WIRE)--Aterian Investment Partners (“Aterian”), a private investment firm, is pleased to announce that one of its affiliates has closed its acquisition of Contract Pharmace...
Aterian Reports First Quarter 2024 Results
First Quarter Net Loss Improved by 80.0% Year Over Year and Adjusted EBITDA Loss Improved by 38.4% Affirms Second Half 2024 Adjusted EBITDA Profitability Target NEW YORK, May 07, 2024 (GLOBE NEWSWIRE)...
Aterian Sets Date for First Quarter 2024 Earnings Announcement & Investor Conference Call
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian”) announced today that it plans to report its first quarter 2024 financial results after the market close on Tuesday...
Aterian Announces Improved First Quarter 2024 Net Revenue and Adjusted EBITDA Ranges
First Quarter Net Revenue Range Improved to $20.0 Million to $21.0 Million First Quarter Adjusted EBITDA Loss Range Improved to ($2.4) Million to ($2.9) Million NEW YORK, April 22, 2024 (GLOBE NEWSWIR...
Aterian Investment Partners to Recapitalize CPL, a Leading Pharmaceutical Contract Development and Manufacturing Organization
NEW YORK & MIAMI--(BUSINESS WIRE)--Aterian Investment Partners (“Aterian”), a private investment firm, is pleased to announce that one of its affiliates has entered into an agreement to recapitalize C...
Aterian Announces Reverse Stock Split
Expected to Start Trading on a Split-adjusted Basis Beginning March 22, 2024 Expected to Start Trading on a Split-adjusted Basis Beginning March 22, 2024
Aterian Reports Fourth Quarter & Full Year 2023 Results
NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced results for the fourth quarter and full year ended December 31, 2023. Fourth Qua...
Aterian Makes Strategic Minority Equity Investment in 4th & Heart
NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced the recent closing of a strategic minority equity investment in 4th & Heart, the ...
Aterian Sets Date for Fourth Quarter & Full Year 2023 Earnings Announcement & Investor Conference Call
NEW YORK, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian”) announced today that it plans to report its fourth quarter and full year 2023 financial results after the market cl...
Aterian Further Strengthens Its Balance Sheet With Extension Of Its Credit Facility
Credit Facility's Financial Liquidity Covenant More Favorable Maturity Extended to December 2026 NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) t...
Aterian Announces Fixed Cost Reduction Plan and Preliminary Fourth Quarter 2023 Results
Expected to Save $4.0 Million Annualized On Target for Second Half 2024 Adjusted EBITDA Profitability Fourth Quarter 2023 Net Revenue Range Improved to $31.2 Million to $32.0 Million Expected Adjusted...
Squatty Potty Re-Launches In Walmart Stores Nationwide
NEW YORK, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Squatty Potty, the toilet stool that positions people how nature intended, reducing their strain while eliminating, announced that select Squatty Potty toil...
Aterian Reports Third Quarter 2023 Results
Reports Third Quarter 2023 Net Revenue of $39.7 Million Third Quarter Net Loss Improves by 94.6% Year Over Year While Adjusted EBITDA Loss Improves by 51.3 % NEW YORK, Nov. 08, 2023 (GLOBE NEWSWIRE) -...
Aterian Sets Date for Third Quarter 2023 Earnings Announcement & Investor Conference Call
NEW YORK, Oct. 27, 2023 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian”) announced today that it plans to report its second quarter 2023 financial results after the market close on Wednesd...
Aterian Receives Extension To Regain Compliance With Nasdaq Minimum Bid Price Rule
NEW YORK, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced that it received written notice (the “Notice”) from The Nasdaq Stock Market LLC (“...
Aterian Reports Second Quarter 2023 Results
NEW YORK, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced results for the second quarter ended June 30, 2023. Second Quarter Highlights Sec...
Aterian Sets Date for Second Quarter 2023 Earnings Announcement & Investor Conference Call
NEW YORK, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian”) announced today that it plans to report its second quarter 2023 financial results after the market close on Tuesday...
Aterian, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK, July 31, 2023 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian”), today announced that it has granted a restricted stock award with respect to 70,000 shares of common stock to a ne...
Aterian Reports First Quarter 2023 Results
Reports First Quarter 2023 Net Revenue of $34.9 Million Announces Headcount Reduction Geared to Achieve Adjusted EBITDA Profitability Target NEW YORK, May 09, 2023 (GLOBE NEWSWIRE) -- Aterian, Inc. (N...
Aterian Sets Date for First Quarter 2023 Earnings Announcement & Investor Conference Call
NEW YORK, April 27, 2023 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian”) announced today that it plans to report its first quarter 2023 financial results after the market close on Tuesday...
Aterian Announces Updated First Quarter 2023 Net Revenue and Adjusted EBITDA Ranges
First Quarter Revenue Between $34.0 Million to $35.0 Million First Quarter Adjusted EBITDA Loss Range Improved to $(3.9) Million to $(4.5) Million NEW YORK, April 19, 2023 (GLOBE NEWSWIRE) -- Aterian,...
Aterian, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK, March 31, 2023 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian”), today announced that it has granted restricted stock awards with respect to 140,000 shares of common stock to two...
Aterian Reports Fourth Quarter & Full Year 2022 Results
NEW YORK, March 09, 2023 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced results for the fourth quarter and full year ended December 31, 2022.
Aterian Announces Further Expansion in Europe
Products Now Selling in Five European Countries Products Now Selling in Five European Countries